• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒感染及其相关肝细胞癌的表观遗传修饰。

Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma.

机构信息

Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.

出版信息

Virulence. 2024 Dec;15(1):2421231. doi: 10.1080/21505594.2024.2421231. Epub 2024 Nov 20.

DOI:10.1080/21505594.2024.2421231
PMID:39460469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11583590/
Abstract

Hepatitis B virus (HBV) infection poses a challenge to global public health. Persistent liver infection with HBV is associated with an increased risk of developing severe liver disease. The complex interaction between the virus and the host is the reason for the persistent presence of HBV and the risk of tumor development. Chronic liver inflammation, integration of viral genome with host genome, expression of HBx protein, and viral genotype are all key participants in the pathogenesis of hepatocellular carcinoma (HCC). Epigenetic regulation in HBV-associated HCC involves complex interactions of molecular mechanisms that control gene expression and function without altering the underlying DNA sequence. These epigenetic modifications can significantly affect the onset and progression of HCC. This review summarizes recent research on the epigenetic regulation of HBV persistent infection and HBV-HCC development, including DNA methylation, histone modification, RNA modification, non-coding RNA, etc. Enhanced knowledge of these mechanisms will offer fresh perspectives and potential targets for intervention tactics in HBV-HCC.

摘要

乙型肝炎病毒 (HBV) 感染对全球公共卫生构成挑战。HBV 的持续肝脏感染与发生严重肝脏疾病的风险增加相关。病毒和宿主之间的复杂相互作用是 HBV 持续存在和肿瘤发展风险的原因。慢性肝脏炎症、病毒基因组与宿主基因组的整合、HBx 蛋白的表达以及病毒基因型都是肝细胞癌 (HCC) 发病机制中的关键参与者。HBV 相关 HCC 的表观遗传调控涉及控制基因表达和功能的分子机制的复杂相互作用,而不会改变潜在的 DNA 序列。这些表观遗传修饰可以显著影响 HCC 的发生和进展。本综述总结了 HBV 持续感染和 HBV-HCC 发展的表观遗传调控的最新研究,包括 DNA 甲基化、组蛋白修饰、RNA 修饰、非编码 RNA 等。对这些机制的深入了解将为 HBV-HCC 的干预策略提供新的视角和潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/d3ab583044d4/KVIR_A_2421231_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/4de1789b62b1/KVIR_A_2421231_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/268bbcc974dd/KVIR_A_2421231_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/bb4075d039a3/KVIR_A_2421231_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/d3ab583044d4/KVIR_A_2421231_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/4de1789b62b1/KVIR_A_2421231_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/268bbcc974dd/KVIR_A_2421231_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/bb4075d039a3/KVIR_A_2421231_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d289/11583590/d3ab583044d4/KVIR_A_2421231_F0004_OC.jpg

相似文献

1
Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma.乙型肝炎病毒感染及其相关肝细胞癌的表观遗传修饰。
Virulence. 2024 Dec;15(1):2421231. doi: 10.1080/21505594.2024.2421231. Epub 2024 Nov 20.
2
Epigenetic Modifications in HBV-Related Hepatocellular Carcinoma.乙型肝炎病毒相关肝细胞癌中的表观遗传修饰
J Viral Hepat. 2025 Feb;32(2):e14044. doi: 10.1111/jvh.14044.
3
Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.乙型肝炎病毒 X 蛋白诱导的异常表观遗传修饰导致人类肝细胞癌的发病机制。
Mol Cell Biol. 2013 Aug;33(15):2810-6. doi: 10.1128/MCB.00205-13. Epub 2013 May 28.
4
Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma.乙型肝炎病毒 X 蛋白在肝细胞癌发病机制中的表观遗传改变。
Hepatol Int. 2022 Aug;16(4):741-754. doi: 10.1007/s12072-022-10351-6. Epub 2022 Jun 1.
5
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.乙型肝炎病毒相关肝细胞癌中癌症和免疫途径的表观遗传调控:HBx 和 miRNA 失调的影响。
Front Immunol. 2021 Apr 29;12:661204. doi: 10.3389/fimmu.2021.661204. eCollection 2021.
6
Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan.乙型肝炎病毒X蛋白通过上调KIAA1429甲基转移酶以及HSPG2/基底膜聚糖的mRNA m6A超甲基化促进肝细胞癌的发生。
Mol Carcinog. 2025 Jan;64(1):108-125. doi: 10.1002/mc.23830. Epub 2024 Oct 16.
7
Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.乙型肝炎病毒相关肝细胞癌中肿瘤与病毒基因组特征的整合
Gut. 2015 May;64(5):820-9. doi: 10.1136/gutjnl-2013-306228. Epub 2014 Jun 9.
8
Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.乙型肝炎病毒对IIA组磷脂酶A2表达的促进作用。
Lipids Health Dis. 2017 Jan 11;16(1):5. doi: 10.1186/s12944-016-0400-7.
9
Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.通过文本挖掘和大数据分析对乙型肝炎病毒相关性肝细胞癌研究的综合回顾。
Biol Rev Camb Philos Soc. 2019 Apr;94(2):353-367. doi: 10.1111/brv.12457. Epub 2018 Aug 13.
10
Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).活化诱导胞苷脱氨酶/载脂蛋白B信使核糖核酸编辑酶、催化多肽样胞苷脱氨酶表达、乙型肝炎病毒(HBV)复制与HBV相关肝病之间的关联(综述)
Mol Med Rep. 2015 Nov;12(5):6405-14. doi: 10.3892/mmr.2015.4312. Epub 2015 Sep 10.

引用本文的文献

1
Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation.蟾毒灵通过阻断表皮生长因子受体(EGFR)介导的RAS-RAF-MEK-ERK信号通路激活来抑制肝癌进展。
J Exp Clin Cancer Res. 2025 Aug 29;44(1):260. doi: 10.1186/s13046-025-03531-3.
2
Mechanism of METTL14 regulates HBV-HCC malignant progression by mediating m6A modification of FOXP3 and thus transcriptional activation of ALDOB.METTL14通过介导FOXP3的m6A修饰从而激活ALDOB转录来调控HBV-HCC恶性进展的机制。
J Mol Histol. 2025 Aug 8;56(4):259. doi: 10.1007/s10735-025-10551-y.
3
Historical and Emerging Trends in Hepatitis B Virus Integration: A Bibliometric Visual Analysis.

本文引用的文献

1
Hepatitis B Virus X Protein Represses Expression of Tumor Suppressor PTPN18 in Hepatocellular Carcinoma.乙型肝炎病毒 X 蛋白抑制肝癌中肿瘤抑制因子 PTPN18 的表达。
Mol Cancer Res. 2024 Sep 4;22(9):891-901. doi: 10.1158/1541-7786.MCR-23-0696.
2
Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription.乙型肝炎病毒共价闭合环状DNA及微型染色体形成机制与乙肝病毒基因转录
Viruses. 2024 Apr 15;16(4):609. doi: 10.3390/v16040609.
3
MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5.
乙型肝炎病毒整合的历史与新趋势:文献计量可视化分析
Hepat Med. 2025 Jul 18;17:39-59. doi: 10.2147/HMER.S526977. eCollection 2025.
4
Bioinformatics identification of key microRNA-correlated genes associated with hepatocellular carcinoma heterogeneity and prognosis.与肝细胞癌异质性和预后相关的关键微小RNA相关基因的生物信息学鉴定
BMC Gastroenterol. 2025 Jul 1;25(1):452. doi: 10.1186/s12876-025-04031-6.
5
Oncogenic viruses rewire the epigenome in human cancer.致癌病毒在人类癌症中重塑表观基因组。
Front Cell Infect Microbiol. 2025 Jun 10;15:1617198. doi: 10.3389/fcimb.2025.1617198. eCollection 2025.
6
HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.乙肝病毒核心蛋白增强WDR46稳定性以上调NUSAP1并促进肝癌进展。
Hepatol Commun. 2025 May 6;9(5). doi: 10.1097/HC9.0000000000000680. eCollection 2025 May 1.
7
EP300 Modulates MCM8 Transcription and Augments the Malignant Phenotype of Hepatitis B Virus-Positive Hepatocellular Carcinoma Cells.EP300调节MCM8转录并增强乙型肝炎病毒阳性肝癌细胞的恶性表型。
Kaohsiung J Med Sci. 2025 Jun;41(6):e70006. doi: 10.1002/kjm2.70006. Epub 2025 Mar 17.
微小RNA-186-5p通过靶向甲基转移酶样3来抑制肝细胞癌进展,甲基转移酶样3可调节m6A介导的卵泡抑素样蛋白5的稳定性。
Heliyon. 2024 Feb 29;10(5):e26767. doi: 10.1016/j.heliyon.2024.e26767. eCollection 2024 Mar 15.
4
Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study.血清 microRNA 谱及乙型肝炎相关性肝细胞癌中的通路:南非研究。
Int J Mol Sci. 2024 Jan 12;25(2):975. doi: 10.3390/ijms25020975.
5
METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression.METTL3/YTHDC1介导的LINC00294上调促进肝细胞癌进展。
Heliyon. 2023 Nov 23;9(12):e22595. doi: 10.1016/j.heliyon.2023.e22595. eCollection 2023 Dec.
6
NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication.NSUN2 介导的 HBV RNA m5C 修饰正向调控 HBV 复制。
PLoS Pathog. 2023 Dec 4;19(12):e1011808. doi: 10.1371/journal.ppat.1011808. eCollection 2023 Dec.
7
LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.长链非编码 RNA FTO-IT1 通过调节 FTO 介导的 GLUT1 和 PKM2 上的 N6-甲基腺苷修饰促进肝细胞癌的糖酵解和进展。
J Exp Clin Cancer Res. 2023 Oct 16;42(1):267. doi: 10.1186/s13046-023-02847-2.
8
EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis.乙型肝炎病毒X抗原通过EZH2介导的肿瘤抑制性let-7c/miR-99a簇表观遗传沉默增强肝细胞癌的进展和转移。
Cancer Cell Int. 2023 Sep 9;23(1):199. doi: 10.1186/s12935-023-03002-9.
9
Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg-positive patients with functional cure following PEG-IFN-based therapy.基于 PEG-IFN 治疗后实现功能性治愈的 HBsAg 阳性患者肝内,整合的 HBV DNA 和 cccDNA 维持转录活性。
Aliment Pharmacol Ther. 2023 Nov;58(10):1086-1098. doi: 10.1111/apt.17670. Epub 2023 Aug 29.
10
The dual functions of KDM7A in HBV replication and immune microenvironment.KDM7A在乙肝病毒复制和免疫微环境中的双重作用。
Microbiol Spectr. 2023 Aug 25;11(5):e0164123. doi: 10.1128/spectrum.01641-23.